Indoco Remedies Ltd Share Price Target From 2025 to 2030

Indoco Remedies Ltd, a leading pharmaceutical company, has established itself as a strong player in the Indian pharma sector. With a history of innovation, research-driven growth, and consistent performance in both domestic and international markets, Indoco Remedies continues to attract investor attention. In this article, we will explore Indoco Remedies’ share price targets from 2025 to 2030, along with investment insights based on fundamentals and market outlook.

Let’s first look at Indoco Remedies’ current stock details and performance.

Indoco Remedies Share Price Today (As of August 29, 2025)

About Indoco Remedies Ltd

Founded in 1947, Indoco Remedies Ltd is an integrated, research-focused pharmaceutical company headquartered in Mumbai. The company operates across formulations, active pharmaceutical ingredients (APIs), and contract manufacturing. Indoco has a strong presence in India and exports to more than 55 countries worldwide.

Key Highlights:

• Over 75 years of expertise in pharmaceuticals

• Strong R&D focus with multiple patents filed

• Manufacturing facilities approved by USFDA, UKMHRA, and WHO

• Strong domestic footprint and robust export business

• Trusted by global partners for contract research and manufacturing

Indoco Remedies Shareholding Pattern (August 2025)

This healthy promoter holding and institutional support reflect long-term confidence in the company.

Indoco Remedies Ltd Share Price Target 2025 to 2030

These projections are based on financial performance, earnings per share (EPS), P/E ratio, and sectoral growth trends in pharma.

Year-Wise Analysis & Investment Advice

Indoco Remedies Share Price Target 2025: ₹290 – ₹320

By 2025, Indoco Remedies is expected to maintain steady growth in domestic formulations and exports.

Why?

• Expanding generic drug portfolio

• Strong demand in regulated markets

• Low beta indicates stability against market volatility

Investment Advice: Investors can accumulate during corrections and hold for steady compounding.

Indoco Remedies Share Price Target 2026: ₹340 – ₹370

In 2026, the company is expected to benefit from approvals in the US and European markets.

Why?

• Higher revenue from USFDA-approved plants

• Strong order book in contract manufacturing

• Increasing trust in Indian pharma exports

Investment Advice: A good time to hold for medium-term gains; monitor quarterly export growth.

Indoco Remedies Share Price Target 2027: ₹380 – ₹410

By 2027, growth momentum could accelerate with expansion in branded generics and APIs.

Why?

• Entry into new therapeutic categories

• Growing market share in ophthalmic and respiratory drugs

• Better operational efficiency and margins

Investment Advice: Consider reinvesting dividends and continue SIPs for long-term wealth creation.

Indoco Remedies Share Price Target 2028: ₹420 – ₹455

In 2028, Indoco Remedies is projected to see stronger financials and consistent earnings growth.

Why?

• Stronger global footprint in regulated markets

• Increased exports to Africa and Latin America

• Improved book value per share

Investment Advice: Attractive stock for long-term investors seeking stability and growth.

Indoco Remedies Share Price Target 2029: ₹460 – ₹500

By 2029, Indoco Remedies could touch new highs, supported by research-driven products.

Why?

• Rising global demand for affordable generics

• Partnerships with multinational pharma companies

• Strong promoter and institutional backing

Investment Advice: Ideal for long-term investors aiming at 5–7 years wealth creation.

Indoco Remedies Share Price Target 2030: ₹510 – ₹560

By 2030, Indoco Remedies is likely to become a stronger mid-cap pharma company with consistent growth.

Why?

• Strategic focus on R&D and high-value formulations

• Diversified global presence

• Expansion in biosimilars and specialty drugs

Investment Advice: Excellent stock for long-term portfolios with potential for high CAGR.

Should You Invest in Indoco Remedies for the Long Term?

Yes, Indoco Remedies Ltd is a fundamentally strong company with robust domestic and global presence. Its stable promoter holding, increasing institutional interest, and focus on innovation make it a reliable stock for long-term investors.

Key Reasons to Invest:

• Strong R&D and approvals from global regulators

• Consistent promoter confidence with 58.90% holding

• Potential growth in exports and contract research

• Solid financials with low volatility (Beta 0.77)

Risks to Watch Out For:

• Regulatory risks in USFDA and EU approvals

• Competition from other Indian pharma players

• Dependency on global pricing pressures in generics

Always consult a financial advisor before making investment decisions.

Conclusion

Indoco Remedies Ltd has the potential to deliver strong returns in the coming years. With its current price at around ₹277.95, analysts believe it could reach between ₹510 – ₹560 by 2030. Investors looking for stability, growth, and long-term compounding in the pharmaceutical sector can consider Indoco Remedies as a part of their portfolio.

Frequently Asked Questions (FAQs) about Indoco Remedies Ltd

1. What is the current share price of Indoco Remedies Ltd?
As of August 29, 2025, the share price is around ₹277.95.

2. What is the 52-week high and low of Indoco Remedies stock?
The 52-week high is ₹383.00 and the 52-week low is ₹190.00.

3. What is the market capitalization of Indoco Remedies Ltd?
The company’s market cap is around ₹2,801 crore.

4. What is the dividend yield of Indoco Remedies?
The dividend yield stands at 0.07%.

5. What is the face value of Indoco Remedies shares?
The face value of each share is ₹2.

6. Who holds the majority of shares in Indoco Remedies?
Promoters hold 58.90% of the company’s shares.

7. What is the long-term target for Indoco Remedies by 2030?
By 2030, the share price is projected to reach ₹510 – ₹560.

8. Is Indoco Remedies a good stock to invest in?
Yes, it is a stable mid-cap pharma stock with strong growth prospects.

9. What is the book value per share of Indoco Remedies?
The book value per share is ₹118.11.

10. Is Indoco Remedies a safe investment for long-term investors?
With low beta (0.77) and strong fundamentals, Indoco Remedies is considered safe for long-term investors, though regulatory risks must be monitored.